IOVANCE BIOTHERAPEUT

IOVA
Delayed Quote. Delayed  - 09/22 04:00:00 pm
24.96USD +1.50%

Turn to zoom
Prev.24.5900
Open24.6900
High25.2400
Low24.4200
Volume924 005
Latest news
08/19
08/06
08/06
08/05
Chart IOVANCE BIOTHERAPEUTICS, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralBearish
Resistance25,533,130,1
Spread/Res.-2,0%-25%-17%
Spread/Supp.11%53%39%
Support22,516,317,9
Financials
Sales 2021 - - -
Net income 2021 -319 M - -
Net cash 2021 506 M - -
P/E ratio 2021 -11,9x
Yield 2021 -
Capitalization 3 870 M 3 870 M -
EV / Sales 2021 -
EV / Sales 2022 1 022x
Nbr of Employees 241
Free-Float 92,3%
Company
Iovance Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to eradicate cancer cells. The...

>> Read more
Sector :
Bio Diagnostics & Testing
Calendar :
2021-11-10 Earnings Release
Trading Rating :
Investor Rating : -

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 14
Last Close Price 24,96 $
Average target price 40,38 $
Spread / Average Target 61,8%